テキサスにおける湿疹の臨床試験
テキサス内の拠点で、湿疹に関する11件の研究が参加者を募集しています。
テキサス内の都市
公式研究テキスト（英語）
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
- Clinical Site 102, College Station
- Clinical Site 104, San Antonio
被験者募集中第1相健康なボランティア歓迎
18歳〜65歳 · 全性別 · 2026/09/29更新 · NCT07453602Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Arlington
- Novartis Investigative Site, Cypress
- Novartis Investigative Site, Dallas
- 他2件
被験者募集中第2相
18歳〜100歳 · 全性別 · 2026/09/28更新 · NCT06947993A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Texas Dermatology and Laser Specialists, San Antonio
被験者募集中第3相
2歳〜11歳 · 全性別 · 2026/09/25更新 · NCT06807281First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
- Texas Dermatology and Laser Specialists, San Antonio
被験者募集中第1相健康なボランティア歓迎
18歳〜65歳 · 全性別 · 2026/09/25更新 · NCT07527923A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
- Texas Dermatology and Laser Specialists, San Antonio
被験者募集中第3相
6歳〜11歳 · 全性別 · 2026/09/25更新 · NCT06807268Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
- Harrison Dermatology, Missouri City
被験者募集中観察研究
12歳〜89歳 · 全性別 · 2026/09/15更新 · NCT07645820A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)
- ALS Global, Irving
被験者募集中第2/3相
18歳〜80歳 · 全性別 · 2026/09/04更新 · NCT07355075A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Progressive Clinical Research, PA, San Antonio
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/08/28更新 · NCT07599813A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 8, Southlake
被験者募集中第2相
18歳〜74歳 · 全性別 · 2026/08/12更新 · NCT07037901A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- Dermatology Treatment and Research Center, Dallas
- North Texas Center for Clinical Research, Frisco
- DCT-Stone Oak, LLC dba Discovery Clinical Trials, San Antonio
- 他1件
被験者募集中第2相
18歳以上 · 全性別 · 2026/05/04更新 · NCT05995964Flourish: Exploring the Early Infant Gut Microbiome
- Seeding Labs INC, Austin
被験者募集中健康なボランティア歓迎
0 Months – 3 Months · 全性別 · 2026/02/24更新 · NCT07333482ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。